论文部分内容阅读
呼吸衰竭急性恶化时的治疗,以呼吸机管理为中心,最近20年来有了飞速的进步,随着这种情况告一段落,长期几乎被遗忘的呼吸刺激药,又重新引起人们的注意。重新评价此药的工作正在不引人注目地进行着.治疗慢性呼吸器疾病,到底能多大程度地使用呼吸刺激药,今后的动向是值得注意的。此刻,说呼吸刺激药必要也可以,说它不必要(适应症不多)也可以.这里暂且站在认为必要的立场,从病理生理学方面,观察一下它的有用性,并谈一下临床应用中的情况及存在的问题.【低通气机理与呼吸刺激药】
Treatment of patients with acute worsening of respiratory failure, centered on ventilator management, has progressed rapidly over the last 20 years, and as this has ended, the long-forgotten respiratory stimulant has rekindled people’s attention. The reevaluation of the drug is under-taking, and it is noteworthy that treatment of chronic respiratory diseases should be used to a large extent with respiratory stimulants. At the moment, it is okay to say that respiratory irritation medicine is necessary, that it is not necessary (not many indications), here for the time being the position necessary, from the pathophysiology, to observe its usefulness, and talk about clinical applications The situation and existing problems. [Low ventilation mechanism and respiratory stimulant]